Abstract
Herpes Zoster (HZ) is a neurocutaneous disease caused by reactivation of latent Varicella Zoster Virus (VZV). Although up to 20% of people develop shingles during their lifetime, it predominantly affects older individuals. The lifetime recurrent rate of HZ in the general population is approximately 1-6%, and it is increased in people with advanced age, disease, and compromised immune system. It may progress to post-herpetic neuralgia (PHN), leading to significant dysfunction, debility, and morbidity. It is believed that VZV vaccination renders a cost-effective way of protection from shingles and alleviates post-herpetic complications. However, CDC reported less than 30% target vaccination rate based on Healthy People 2020. We present a case of recurrent shingles in an individual with severe chronic obstructive pulmonary disease on long-term corticosteroid therapy. This case illustrates the importance of vaccinations among older people.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
